BWX vs Centrus Energy: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BWX Technologies Inc (BWXT)

Q3 202622 Jul – 12 Aug 2026

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.
This is a new, major demand driver that expands BWXT's addressable market.
Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.
This is the core financial update that directly lifts investor expectations and the stock price.
Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.
This strategic move frees up capital and refocuses the company on higher-growth areas.
Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.
A record backlog is a key indicator of future sales and earnings power.

August 202622 Jul – 12 Aug 2026

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.
This is a new, major demand driver that expands BWXT's addressable market.
Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.
This is the core financial update that directly lifts investor expectations and the stock price.
Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.
This strategic move frees up capital and refocuses the company on higher-growth areas.
Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.
A record backlog is a key indicator of future sales and earnings power.

Latest22 Jul – 12 Aug 2026

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.
This is a new, major demand driver that expands BWXT's addressable market.
Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.
This is the core financial update that directly lifts investor expectations and the stock price.
Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.
This strategic move frees up capital and refocuses the company on higher-growth areas.
Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.
A record backlog is a key indicator of future sales and earnings power.

Q2 202617 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 202617 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

17 Jun – 7 Jul 2026

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.
New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.
Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.
Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.
Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.
New analyst actions reflect improving sentiment and can influence short-term demand for the stock.
Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.
New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

Centrus Energy Corp. (LEU)

Q3 202622 Jul – 21 Aug 2026

▲4

Centrus Expands HALEU Lead with Earnings Beat and New Military Market

U.S.-Saudi Nuclear Pact Opens New Demand The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that gives American companies a central role and could allow uranium enrichment on Saudi soil. Centrus, as a U.S. fuel supplier, is positioned to benefit from this new demand.
This is a new geopolitical event that expands the market for Centrus's core products.
Q2 Earnings Beat and Backlog Grows to $4.5B Centrus reported Q2 revenue up 14% to $176.1 million, beating estimates, with backlog rising to $4.5 billion. The company also signed a $900 million DOE HALEU award and selected a construction contractor for expansion, though cash used in operations and higher capex are watch items.
This is a new earnings report that confirms financial strength and growing demand.
X-Energy Secures $1B More, Signs Centrus Deal X-Energy will receive up to $1 billion more in DOE funding and has signed long-term enrichment agreements with Centrus. This locks in a key customer for Centrus's HALEU output, supporting future revenue.
This is a new customer commitment that directly boosts Centrus's order book.
CEO Eyes U.S. Military as New Market Centrus CEO said a U.S. government contract to supply enriched uranium for defense could be finalized this year, opening a new market for Navy fuel and tritium. This would add a stable, high-value revenue stream.
This is a new potential market that could significantly expand Centrus's customer base.

August 202622 Jul – 21 Aug 2026

▲4

Centrus Expands HALEU Lead with Earnings Beat and New Military Market

U.S.-Saudi Nuclear Pact Opens New Demand The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that gives American companies a central role and could allow uranium enrichment on Saudi soil. Centrus, as a U.S. fuel supplier, is positioned to benefit from this new demand.
This is a new geopolitical event that expands the market for Centrus's core products.
Q2 Earnings Beat and Backlog Grows to $4.5B Centrus reported Q2 revenue up 14% to $176.1 million, beating estimates, with backlog rising to $4.5 billion. The company also signed a $900 million DOE HALEU award and selected a construction contractor for expansion, though cash used in operations and higher capex are watch items.
This is a new earnings report that confirms financial strength and growing demand.
X-Energy Secures $1B More, Signs Centrus Deal X-Energy will receive up to $1 billion more in DOE funding and has signed long-term enrichment agreements with Centrus. This locks in a key customer for Centrus's HALEU output, supporting future revenue.
This is a new customer commitment that directly boosts Centrus's order book.
CEO Eyes U.S. Military as New Market Centrus CEO said a U.S. government contract to supply enriched uranium for defense could be finalized this year, opening a new market for Navy fuel and tritium. This would add a stable, high-value revenue stream.
This is a new potential market that could significantly expand Centrus's customer base.

Latest22 Jul – 21 Aug 2026

▲4

Centrus Expands HALEU Lead with Earnings Beat and New Military Market

U.S.-Saudi Nuclear Pact Opens New Demand The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that gives American companies a central role and could allow uranium enrichment on Saudi soil. Centrus, as a U.S. fuel supplier, is positioned to benefit from this new demand.
This is a new geopolitical event that expands the market for Centrus's core products.
Q2 Earnings Beat and Backlog Grows to $4.5B Centrus reported Q2 revenue up 14% to $176.1 million, beating estimates, with backlog rising to $4.5 billion. The company also signed a $900 million DOE HALEU award and selected a construction contractor for expansion, though cash used in operations and higher capex are watch items.
This is a new earnings report that confirms financial strength and growing demand.
X-Energy Secures $1B More, Signs Centrus Deal X-Energy will receive up to $1 billion more in DOE funding and has signed long-term enrichment agreements with Centrus. This locks in a key customer for Centrus's HALEU output, supporting future revenue.
This is a new customer commitment that directly boosts Centrus's order book.
CEO Eyes U.S. Military as New Market Centrus CEO said a U.S. government contract to supply enriched uranium for defense could be finalized this year, opening a new market for Navy fuel and tritium. This would add a stable, high-value revenue stream.
This is a new potential market that could significantly expand Centrus's customer base.

Q2 202618 Jun – 7 Jul 2026

▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.
This is the key new contract that directly drives LEU's growth story and stock reaction.
Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.
Shows strong demand and financial visibility that underpin LEU's valuation.
S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.
A new event that directly affects stock demand and liquidity.
Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.
Provides a counterweight: even with positive news, external factors can pressure the stock.

June 202618 Jun – 7 Jul 2026

▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.
This is the key new contract that directly drives LEU's growth story and stock reaction.
Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.
Shows strong demand and financial visibility that underpin LEU's valuation.
S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.
A new event that directly affects stock demand and liquidity.
Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.
Provides a counterweight: even with positive news, external factors can pressure the stock.

18 Jun – 7 Jul 2026

▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.
This is the key new contract that directly drives LEU's growth story and stock reaction.
Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.
Shows strong demand and financial visibility that underpin LEU's valuation.
S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.
A new event that directly affects stock demand and liquidity.
Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.
Provides a counterweight: even with positive news, external factors can pressure the stock.